Peter John Nolan
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Peter John Nolan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 29 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter John Nolan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Comptroller/Controller/Auditor Human Resources Officer | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Sales & Marketing | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Oxford Biomedica (UK) Ltd.
 Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Oxxon Therapeutics Ltd.
 Oxxon Therapeutics Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxxon Therapeutics Ltd. is a biotechnology company. Oxxon Therapeutics Ltd. is based in Oxford, UK. Oxxon Therapeutics was acquired by Oxford Biomedica Plc on March 15, 2007 for $24.89 million. The British company was founded in 1998. | Biotechnology | Director/Board Member Director/Board Member | |
Morvus Technology Ltd.
 Morvus Technology Ltd. Pharmaceuticals: GenericHealth Technology Morvus Technology Ltd. discovers, develops and commercializes of novel drugs and technologies in the oncology field. Its products include clinical candidates, research portfolio and non-core programmes. The company was founded by Philip John Burke and Roger Geoffrey Melton in April 2004 and is headquartered in Carmarthen, the United Kingdom. | Pharmaceuticals: Generic | Chairman Director/Board Member | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| MEIRAGTX HOLDINGS PLC | Biotechnology | Corporate Officer/Principal | |
Zytoprotec GmbH
 Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
| University of Warwick | College/University | Undergraduate Degree | |
Southampton Asset Management Ltd.
 Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Investment Managers | Chief Investment Officer | |
Productiv Ltd.
 Productiv Ltd. Industrial ConglomeratesProducer Manufacturing Productiv Ltd. provides technical, production, and commercial development services. the firm offers original equipment manufacturer engagement, cost validation, and supply chain manufacturing and assembly. The company was founded by Robert John Austin on April 12, 2011 and is headquartered in Coventry, the United Kingdom. | Industrial Conglomerates | Director of Finance/CFO | |
| King's College London | College/University | Graduate Degree | |
Sosei Co. Ltd.
 Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sterix Ltd.
 Sterix Ltd. Medical/Nursing ServicesHealth Services Sterix Ltd. provides pharmaceutical research services for oncology and endocrine related diseases. It develops artificial steroid hormones and other drug preparations. The company was founded in 1998 and is headquartered in Oxford, UK. | Medical/Nursing Services | Chairman | |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Chief Executive Officer | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
CeNeS Pharmaceuticals Plc
 CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Innovata Ltd.
 Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| PREMIER VETERINARY GROUP PLC | Agricultural Commodities/Milling | Director/Board Member | |
Quadrant Healthcare Plc
 Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Pharmaceuticals: Major | Director of Finance/CFO |
Statistik
International
| Vereinigtes Königreich | 26 |
| Vereinigte Staaten | 9 |
| Irland | 2 |
| Cayman Islands | 2 |
| Österreich | 2 |
Sektoral
| Health Technology | 21 |
| Commercial Services | 6 |
| Consumer Services | 6 |
| Finance | 5 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 115 |
| Corporate Officer/Principal | 47 |
| Independent Dir/Board Member | 22 |
| Chief Tech/Sci/R&D Officer | 16 |
| Chairman | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Heather Elizabeth Preston | 34 |
| Paul Blake | 23 |
| Andrew Heath | 20 |
| Nick Rodgers | 18 |
| Tim Watts | 17 |
| Don Soland | 14 |
| Lorenzo M. Tallarigo | 11 |
| Rajan Uppal | 8 |
| Stuart Paynter | 8 |
| John Dawson | 8 |
| Nicholas L. Woolf | 8 |
| Stuart Henderson | 7 |
| Jason Slingsby | 7 |
| Martin Diggle | 7 |
| Stuart Naylor | 6 |
- Börse
- Insiders
- Peter John Nolan
- Unternehmensverbindungen